Neither activated charcoal nor whole bowel irrigation (WBI) is indicated in the routine management of acute or chronic lithium toxicity.

Similar documents
Dr Ruwan Parakramawansha MBBS, MD, MRCP(UK),MRCPE, DMT(UK) (2013/04/02)

HYPERCALCEMIA. Babak Tamizi Far MD. Assistant professor of internal medicine Al-zahra hospital, Isfahan university of medical sciences

WESTMEAD PRIMARY EXAM GROUP PSYCHOTROPIC MEDICATIONS

Antidepressants: Prof. Riyadh Al_Azzawi F.R.C.Psych

Salicylate (Aspirin) Ingestion California Poison Control Background 1. The prevalence of aspirin-containing analgesic products makes

M0BCore Safety Profile

Drug Name: Lithium Clinical Indications: Treatment and prophylaxis of mania; bipolar disorder; augmentation therapy in treatment resistant depression

WATER, SODIUM AND POTASSIUM

Lithium Shared Care Protocol and Information for Oxfordshire GPs

LACIPIL QUALITATIVE AND QUANTITATIVE COMPOSITION

PRODUCT INFORMATION RESONIUM A. Na m

Lithium Intoxication with Sinus Node Dysfunction: Report of a Case

PDP 406 CLINICAL TOXICOLOGY

Hematopoiesis, The hematopoietic machinery requires a constant supply iron, vitamin B 12, and folic acid.

PRODUCT INFORMATION QUILONUM SR

Amjad Bani Hani Ass.Prof. of Cardiac Surgery & Intensive Care FLUIDS AND ELECTROLYTES

Anti-Depressant Medications

Generalized Anxiety Disorder ( DSM -IV) is characterized by excessive anxiety and worry (apprehensive expectation) that is persistent for at least 6

POMH-UK QUALITY IMPROVEMENT PROGRAMME LITHIUM MONITORING. Thomas R. E. Barnes

PHARMACEUTICAL INFORMATION AZILSARTAN

KELFER Deferiprone. COMPOSITION KELFER-250 Capsules Each capsule contains Deferiprone 250 mg

SUMMARY OF PRODUCT CHARACTERISTICS

ELECTROLYTES RENAL SHO TEACHING

TRAPADOL INJECTION FOR I.V./I.M. USE ONLY

SUMMARY OF PRODUCT CHARACTERISTICS

CLINICAL GUIDELINES ID TAG

Depression: selective serotonin reuptake inhibitors

Basic Fluid and Electrolytes

Correspondence should be addressed to Levent Demirtas;

Clinical Toxicology Toxicity of Digitalis Glycosides 5 th Year (Lab 3)

KELFER Capsules (Deferiprone)

IV Fluids. I.V. Fluid Osmolarity Composition 0.9% NaCL (Normal Saline Solution, NSS) Uses/Clinical Considerations

Salicylates commonly cause tinnitus, deafness, nausea and vomiting (salicylism). Hyperventilation results from stimulation of respiratory centre.

LITHIUM CARBONATE Extended Release Tablets USP, 450 mg

1995 Called - They Want Your Boring Lectures Back Bringing Tech into the Classroom

INSPRA 25 & 50 mg TABLETS

Each tablet contains:

Chapter 13. Learning Objectives. Learning Objectives 9/11/2012. Poisonings, Overdoses, and Intoxications

DISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics.

Clinical Pathway: Management Of The Life-Threatening Overdose

Normal range of serum potassium is meq/l true hyperkalemia manifests clinically as : Clinical presentation : muscle and cardiac dysfunction

COMPOSITION. A film coated tablet contains. Active ingredient: irbesartan 75 mg, 150 mg or 300 mg. Rotazar (Film coated tablets) Irbesartan

PHA 5127 FINAL EXAM FALL On my honor, I have neither given nor received unauthorized aid in doing this assignment.

LITHICARB Lithium carbonate

NEW ZEALAND DATA SHEET 1. PRIADEL MODIFIED RELEASE TABLETS 400 MG 2. QUALITATIVE AND QUANTITATIVE COMPOSITION

(levomilnacipran) extended-release capsules

Depression in Pregnancy

Calcium (Ca 2+ ) mg/dl

LITHIUM. Generic? Yes

How effective is chelation? contrasts in iron and digoxin poisoning. Nick Bateman Edinburgh

Major intra and extracellular ions Lec: 1

PRODUCT INFORMATION. SUDAFED Sinus 12 Hour Relief Tablets

Levocetirizine dihydrochloride

Rytmonorm/Arythmol (propafenone) SR 225 mg, 325 mg, 425 mg Capsules and IR 10 mg, 150 mg, 300 mg Tablets and Intravenous Solution for Injection

DRUGS THAT ACT IN THE CNS

Michael Kozart, MD, PhD

SPIMACO. Escitalopram oxalate

Hypoglycemia, Electrolyte disturbances and acid-base imbalances

Kelly Godecke, MD Department of Psychiatry University of Utah

ECG & ELECTROLYTES IMBALANCE

Department of Neurology, Brown University; 593 Eddy St APC Building 5th loor, Providence, RI, USA

NEW ZEALAND DATA SHEET

Protocol for Iron poisoning management Category/Use: Iron supplements are used for the prevention and treatment of iron deficiency

Diuretic Agents Part-2. Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia

NOTOPAIN CAPLETS. Diclofenac Sodium + Paracetamol. Composition. Each tablet contains: Diclofenac Sodium BP 50mg Paracetamol BP 500mg.

Pare. Blalock. Shires. shock caused by circulating toxins treatment with phlebotomy. shock caused by hypovolemia treatment with plasma replacement

ROS: all remaining ROS negative

PEDIATRIC SVT MANAGEMENT

Disorders of water and sodium homeostasis. Prof A. Pomeranz 2017

Contraindications Hypersensitivity Fluoxetine is contraindicated in patients known to be hypersensitive to Fluoxetine.

1/3/2008. Karen Burke Priscilla LeMone Elaine Mohn-Brown. Medical-Surgical Nursing Care, 2e Karen Burke, Priscilla LeMone, and Elaine Mohn-Brown

Bipolar Disorders. Disclosure Statement. I have no financial disclosures or conflicts of interest

PRODUCT INFORMATION. Sudafed* Sinus + Anti-inflammatory Pain Relief Caplets

Metformin Hydrochloride

Potential Drug Dosing Variability in Women. Jim Beaulieu, PharmD Senior Clinical Pharmacist Specialist Rhode Island Hospital and The Miriam Hospital

Elements for a Public Summary. VI.2.1 Overview of disease epidemiology

Electrolyte Imbalance and Resuscitation. Dr. Mehmet Okumuş Sütçü Imam University Faculty of Medicine Department of Emergency Medicine

DOSAGE AND ADMINISTRATION

a lecture series by SWESEMJR

Parsabiv the control of calcimimetic delivery you ve always wanted, the sustained lowering of shpt lab values your patients deserve 1

New Zealand Data Sheet

NEW ZEALAND DATA SHEET

Chapter : Sources and Bodily Effect of Drugs

Chapter 149 Aspirin and Nonsteroidal Agents

Example Clinician Educational Material for Providers of Immune Effector Cellular Therapy

2/1/2013. Poisoning pitfalls. The original pitfall

Lithium Prescribing and Monitoring Guidelines

Acid-Base Imbalance-2 Lecture 9 (12/4/2015) Yanal A. Shafagoj MD. PhD

NPSA SAFER LITHIUM THERAPY GUIDELINES FOR NHS LANARKSHIRE

Rini Purwanti Sekretaris PD IPDI Jatim

PARACOD Tablets (Paracetamol + Codeine phosphate)

Composition Each ml of Ventol solution for inhalation contains 5 mg Salbutamol (as sulphate).

The Tipping Point. Brita Roy, MD MPH MS F. Stanford Massie Jr., MD

Care for patients with Neurological disorders

Proceedings of the 34th World Small Animal Veterinary Congress WSAVA 2009

PRODUCT MONOGRAPH K-DUR. (Potassium Chloride) Sustained Release Tablets mg - 20 mmol (meq)

SODIUM POLYSTYRENE SULFONATE Suspension, USP

Protocol for Angiotensin converting enzyme inhibitors (ACEIs) poisoning management

DIGOXIN THERAPEUTIC DRUG ASSAY

Document 3 Summary of Data and Guidance for Medical Professionals

Transcription:

CRACKCast E160 Lithium Key concepts; The clinical pattern of acute and chronic toxicity is different. Gastrointestinal symptoms occur early and neurological toxicity manifest late in acute toxicity. Neurological findings (such as, tremors, clonus, and somnolence) often are presenting signs of chronic lithium toxicity and gastrointestinal symptoms may be absent. Neither activated charcoal nor whole bowel irrigation (WBI) is indicated in the routine management of acute or chronic lithium toxicity. Serial lithium concentrations should be obtained every 2 to 4 hours initially to determine the peak level and the need for dialysis. Fluid hydration with crystalloid is essential to enhance the removal of lithium through the kidney. Diuretics are contraindicated. We recommend dialysis for acute lithium concentrations >4 meq/l (4 mmol/l), and chronic lithium concentrations >2.5 meq/l (2.5 mmol/l), or for patients with signs of severe neurological toxicity regardless of the concentration. Core questions 1. How does lithium work? 2. What is the clinical presentation of lithium toxicity? 3. List risk factors for toxicity in the setting of chronic lithium use. 4. List 4 factors which impair renal filtration of Li 5. List 2 disease states caused by Li 6. Describe the management of lithium toxicity. 7. What are the indications for dialysis in a patient with lithium toxicity? Wisecracks: 1. List 4 common clinical scenarios for Li toxicity and describe the clinical syndromes 2. List the ECG changes potentially seen in lithium toxicity

Rosen s In Perspective: Lithium was approved for the treatment of bipolar disorder in 1970, and it remains one of the most effective agents for both depressive and manic symptoms. Lithium is a monovalent cation with a narrow therapeutic range, and significant toxicity can result when outside of this range. Lithium largely has no effect when given in therapeutic doses to patients without mood disorders. Lithium toxicity is nonspecific and may present in a manner similar to many systemic and neurologic disorders, so obtaining a history of use or ingestion is critical to making the diagnosis. [1] How does lithium work? In spite of long-term therapeutic use, the mechanism by which lithium acts is still not fully understood. Its efficacy in the treatment of psychiatric illnesses is thought to be due to the modulation of neurotransmitters, which has downstream effects through cell signaling and molecular mechanisms. [2] What is the clinical presentation of lithium toxicity? Lithium is rapidly absorbed from the gastrointestinal tract and peaks in the serum 1 to 2 hours after ingestion of immediate release preparation and 4 to 5 hours with sustained release preparations. In overdose situations, absorption and peak concentrations may be delayed. Once absorbed, lithium enters the serum followed by a delayed distribution to the tissues. Lithium is NOT metabolised (it's a metal) and is excreted unchanged in the urine. Unless the patient intentionally overdoses, most toxicity occurs in the setting of acute or chronic intravascular volume depletion or renal impairment The classic presentation of significant lithium toxicity comprises altered mental status; tremors; hyperreflexia, clonus, or fasciculations; and vomiting or diarrhea. However, clinical features of lithium toxicity depend on whether it is acute or chronic in nature (Table 154.1). Thus, evaluation of the potentially lithium toxic patient requires

knowledge of whether the patient was previously taking lithium, the timing of the last dose, and the amount of drug ingested. Acute toxicity = GI symptoms predominate Patient wasn t on lithium and wanted to OD on it Chronic toxicity = neurologic symptoms predominate an increase in serum levels of lithium in a patient who is regularly taking lithium. This can either be from reduced excretion, renal insufficiency, or dose adjustment (either by a clinician or by the patient). Chronic lithium toxicity causes predominantly neurological symptoms. Acute-on-chronic toxicity occurs when a patient with a stable steady-state lithium level takes a substantial additional amount of lithium, whether intentional or accidental. These patients present with a combination of both acute and chronic toxicity signs and symptoms. Either acute or chronic toxicity can result in cardiac conduction abnormalities or bradycardia; Table 154.1: Clinical Features of Lithium Toxicity CLINICAL FEATURES Gastrointestinal 1 Neurological 11,12 Cardiac 13-14 TYPE OF TOXICITY ACUTE Nausea Vomiting Diarrhea Similar to chronic toxicity, occurs several hours after lithium distribution to the brain Sinus node dysfunction AV blockade Brugada pattern on ECG Ischemic changes on ECG QTc prolongation AV, Atrioventricular; ECG, electrocardiogram. CHRONIC Mild or nonexistent Tremors Clonus Hyperreflexia Somnolence Extrapyramidal symptoms Coma Seizures Mnemonic time: Leukostasis Insipidus Tremor / teratogen Hypothyroidism Increased weight

Vomiting? nausea Myocardium = ecg changes Serotonin syndrome / nms like effect [3] List risk factors for toxicity in the setting of chronic lithium use. Nephrogenic DI Renal impairment Acute illness Diuretic use, NSAIDS, ACE/ARB drugs Dementia Increased age SILENT: cerebellar findings with pseudodementia [4] List 4 factors which impair renal filtration of Lithium Volume depletion Kidney injury Nephrogenic DI Diuretic use [5] List 2 disease states caused by Lithium Here s a bunch: nephrogenic diabetes insipidus Hypothyroidism (and hyperthyroidism) Both of these conditions are reversible with discontinuation of the medication and respond well to conventional management. Hypercalcemia and hyperparathyroidism also can occur and reverse upon discontinuation of lithium. Patients chronically taking lithium can develop the syndrome of irreversible lithium-effectuated neurotoxicity (SILENT). Patients with SILENT will often have persistent cerebellar and brainstem dysfunction, dementia, and extrapyramidal signs even after lithium use has been discontinued for more than 2 months. [6] Describe the management of lithium toxicity. Think about other ingestants or your ddx: Toxins:

Salicylates, iron, ASA, acetaminophen, substance withdrawal, serotonin syndrome! Lithium concentrations should be obtained in all patients who are taking lithium, or have access to lithium, and present with potential toxicity. Because of the insidious and nonspecific nature of chronic lithium toxicity, a serum lithium level is also advisable in patients who are on lithium maintenance, regardless of their reason for presentation (normal levels 0.6-1.2 mmol/l) Box 154.1: Diagnostic Testing For Lithium: Serum lithium level Serum electrolytes Electrocardiogram (ECG) If the clinical picture dictates: o Acetaminophen/salicylate levels o Thyroid function tests No specific antidote exists for lithium toxicity, and activated charcoal does not bind lithium. Supportive care and enhanced elimination are the mainstays of treatment. Because lithium is primarily excreted unchanged by the kidney, intravenous crystalloid should be administered early. Most patients who are lithium-toxic are dehydrated because of gastrointestinal losses in acute toxicity or from underlying dehydration leading to chronic toxicity. Crystalloid should be infused as a 1 L bolus followed by a continuous infusion at 150% of the calculated maintenance rate if there are no contraindications, such as congestive heart failure. Diuretics are contraindicated, because they can cause worsening dehydration and reabsorption of lithium. Electrolyte abnormalities, if significant, should be corrected. We do not recommend the use of whole bowel irrigation (WBI) in routine lithium ingestions. - Rosen s [7] What are the indications for dialysis in a patient with lithium toxicity? Lithium is highly dialyzable and dialysis is indicated for patients exhibiting signs of severe lithium toxicity

Dialysis can remove lithium at a rate five to seven times the rate of typical renal elimination. Box 154.2: Indications For Dialysis in Lithium Poisoned Patients 1. Severely symptomatic patients 2. Unable to tolerate fluid hydration 3. Renal impairment 4. Acute toxicity: Levels above 4 meq/l 5. Chronic toxicity: Levels above 2.5 meq/l Wisecracks: [1] List 4 common clinical scenarios for Li toxicity and describe the clinical syndromes Acute toxicity a recent ingestion in a patient who is not therapeutically taking lithium. Acute toxicity typically manifests with gastrointestinal symptoms such as vomiting and diarrhea and can mimic many other disease states. Neurologic consequences of an acute lithium overdose (such as, altered mental status and seizures) occur several hours later after lithium redistributes to the brain, but in some cases where lithium has delayed-release properties, this can occur even 12 or more hours after ingestion. May have cardiac toxicity Acute on chronic toxicity Overlap of GI, Neuro, and cardiotoxicity (AV blockade, qtc prolonged, ischemic changes) Chronic toxicity (reduced excretion, renal insufficiency, dose adjustment (either by a clinician or by the patient). predominantly neurological symptoms = ataxia, EPS, tremors, seizures, coma/somnolence. Lithium has also been implicated in serotonin syndrome when combined with other drugs, such as monoamine oxidase (MAO) inhibitors, selective serotonin reuptake inhibitor (SSRIs), dextromethorphan, and meperidine. Any changes in renal excretion due to conditions such as dehydration, hyponatremia, or renal dysfunction will lead to increases in serum lithium levels.

[2] List the ECG changes potentially seen in lithium toxicity These are usually seen in acute overdose Bradycardia Junctional rhythm / AV blockade ST changes QT prolongation Flattened or inverted T-waves Brugada pattern on ECG Ischemic changes on ECG